The rat placental PRL family consists of proteins structurally related to pituitary PRL. As a consequence of attempting to characterize the gene for one of the members of the family, PRL-like protein-C (PLP-C), we identified a related gene that we have termed PLP-C variant (PLP-Cv). In this study, we present information on the PLP-Cv gene and its pattern of expression. Screening of a rat genomic library with a PLP-C cDNA resulted in the isolation of four phage clones. Nucleotide sequence analysis of the clones revealed a gene, PLP-Cv, closely related but distinct from PLP-C. The PLP-Cv gene possessed a six exon/five intron organization, unique among members of the PRL family, and was localized to chromosome 17 of the rat genome, similar to other PRL family members. A PCR strategy involving primers based on the PLP-Cv gene was used to isolate a placental PLP-Cv cDNA. PLP-Cv showed 90 and 78% sequence identity with PLP-C at nucleotide and amino acid levels, respectively. Expression of PLP-Cv was restricted to the trophoblast lineage and was coordinately activated with PLP-C beginning at day 11 of gestation and continuing until term. Primer extension analysis revealed multiple putative transcription start sites. A 2.1-kilobase pair PLP-Cv promoter-luciferase reporter construct was specifically activated in differentiating rat trophoblast cells but not in other cell types. In conclusion, we have identified a new member of the PRL family possessing considerable homology to PLP-C, a unique gene structure, and displaying a trophoblast-specific pattern of transcriptional activation. (Endocrinology 137: 5009-5019, 1996) 
volving primers based on the PLP-Cv gene was used to isolate a placental PLP-Cv cDNA. PLP-Cv showed 90 and 78% sequence identity with PLP-C at nucleotide and amino acid levels, respectively. Expression of PLP-Cv was restricted to the trophoblast lineage and was coordinately activated with PLP-C beginning at day 11 of gestation and continuing until term. Primer extension analysis revealed multiple putative transcription start sites. A 2.1-kilobase pair PLP-Cv promoter-luciferase reporter construct was specifically activated in differentiating rat trophoblast cells but not in other cell types. In conclusion, we have identified a new member of the PRL family possessing considerable homology to PLP-C, a unique gene structure, and displaying a trophoblast-specific pattern of transcriptional activation. (Endocrinology 137: 5009-5019, 1996) T HE RAT PRL family represents a cluster of several genes located on chromosome 17 (l-3). Members of the family include: PRL (l), placental lactogen-I (PL-I; 4, 5), PL-I variant (PL-Iv; 6,7), PL-II (g-lo), PRL-like protein-A (PLP-A; 9,11,12), PRL-like protein-B (PLP-B; 13), PRL-like protein-C (PLP-C; 14, 15), and decidual/ trophoblast PRL-related protein (d/ tPRP, 16). These genes are expressed by the anterior pituitary, uterus, or placenta during specific phases of pregnancy and participate in the coordination of maternal and fetal tissue responses (2, 3) . Some members of the family (PL-I, PL-Iv, and PL-II) are functional agonists of PRL (17-19) and represent the principal ligands for the PRL receptor, especially during the second half of gestation (20) . PLP-A and PLP-C do not utilize the PRL receptor signaling pathway and appear to possess unique actions (21, 22). Thus far, only the gene structure for PRL has been reported (23-25).
During the course of analyzing the PLP-C gene, we identified a closely related gene that we have termed, PLP-C variant (PLP-Cv). In this report, we present data on the access to food and water. Timed pregnancies and tissue dissections were (32) using oligonucleotide primers corresponding to regions of the I'LP-C performed as previously described (26) . The presence of a copulatory cDNA to sequence all exons and exon/intron boundaries. Sequencing plug or sperm in the vaginal smear was designated day 0 of pregnancy.
reactions used [35S] dATI' and were performed with T7 sequencing kits. Timed pregnant Wistar Kyoto outbred rats were obtained from Taconic Reaction products were resolved in 6% polyacrylamide urea gels, dried, Farms (Germantown, NY). and exposed to Kodak XAR film. Protocols for the care and use of animals were approved by the University of Kansas Animal Care and Use Committee.
Chromosomal assignment Cell lines
A series of trophoblast and nontrophoblast cell lines were examined for their ability to express PLP-Cv. The Rcho-1 trophoblast cell line was derived from a rat choriocarcinoma and is capable of differentiating along the trophoblast giant cell lineage (27). Rcho-1 trophoblast cells were routinely maintained in subconfluent conditions with NCTC-135 culture medium supplemented with 20% FBS, 50 PM 2-mercaptoethanol, 1 mrvr sodium pyruvate, 100 U/ml of penicillin, and 100 Kg/ml of streptomycin (27). Differentiation was induced by growing the cells to confluence in FBS supplemented culture medium and then replacing the serum supplementation with 10% HS (28, 29). HIV-1 trophoendodermal stem cell line represents a cell population with both trophoblast and yolk sac attributes (30). HRP-1 trophoendodermal cells were routinely maintained in RPMI-1640 culture medium containing 10% FBS and the above supplements. GH, cells were derived from a rat pituitary tumor (31) and were maintained in DMEM culture medium supplemented with 10% FBS and antibiotics. L929 cells represent a mouse fibroblast cell line and were maintained in RPMl culture medium supplemented with 10% FBS and antibiotics.
Cell hybrids used in the chromosomal localization of the PLP-Cv gene were derived from the fusion of mouse hepatoma cells (BWTG3) with adult rat hepatocytes and have been used in the chromosomal assignment of several rat genes (33). Chromosomal preparations were generated as previously reported (34, 35) . DNA was extracted and analyzed by PCR using primers specific for PLP-Cv. The PCR reaction was performed for 35 cycles (denature, 94 C for 30 set; annealing and extension, 68 C for 6 min). Reaction products were electrophoretically separated in 1% agarose gels, transferred to nylon membranes, and probed with a [32P]-labeled PLP-Cv cDNA (36) .
Zsolation and characterization of the PLP-Cv cDNA Zsolation and characterization of the PLP-Cv gene A genomic DNA library generated from lZweek-old male Wistar Kyoto outbred rat liver and packaged in the Lambda DASH II vector was obtained from Stratagene. The library was screened with a rat PLP-C cDNA as previously described (15). Positive plaques were amplified and used to inoculate LE392 Escherechiu coli. Phage DNA from four positive clones was isolated, spotted on to nylon membranes and probed with oligonucleotides representing either the 5' or 3' end of the PLP-C cDNA. The oligonucleotides were end-labeled with T4 polynucleotide kinase and [r3 I'] ATP. Th e genomic DNA was excised with Not1 and then partially digested with HindIII, BamHl, and Xbal to generate a restriction map. Restriction fragments containing exons were obtained by complete digestion with these restriction enzymes and Southern blotting with a radiolabeled PLP-C cDNA probe. HindIIl restriction fragments hybridizing to the PLP-C cDNA were subcloned into pBluescript sk+ vector (Stratagene) for sequencing. DNA sequencing was performed by the dideoxy chain termination method Specific primers for the amplification of the PLP-Cv cDNA were designed based on sequences from the 5' and 3' untranslated regions of the PLP-C cDNA and the corresponding sequences predicted for the PLP-Cv cDNA from the sequence of the PLP-Cv gene. Total RNA was extracted with TRIzol Reagent (Life Technologies) from the junctional zone of the rat chorioallantoic placenta on day 19 pregnancy. RT-PCR was performed according to the manufacturer's instructions (SuperScript preamplification system for first strand cDNA Synthesis Kit, Life Technologies). Five pg of total placental RNA and 0.5 PLg of oligo(deoxythymidine)
were used for the RT reaction. The PCR reaction was performed for 30 cycles (denature, 94 C for 1 min; annealing, 60 C for 2 min; extension, 72 C for 2 min). The amplified products were subcloned into the pCR II vector flanked by Sp6 and T7 promoters (Invitrogen) and sequenced as described above. Oligonucleotides complementary to the Sp6 and T7 promoters and to two internal segments of the PLP-Cv cDNA were used as primers for the sequencing reactions.
Tissue distribution of PLP-C and PLP-Cv expression Total RNA was extracted from a range of different rat tissues including, spleen, liver, thymus, hypothalamus, anterior pituitary, ovary, uterus, decidua, and the labyrinth and junctional zones of the rat chorioallantoic placenta and from the Rcho-1 trophoblast, L929 fibroblast, GH, pituitary, and HRP-1 trophoendodermal cell lines, with the TRIzol +200   G TTC  ACT  CTA  TAT  CAT  CTC  AGA  ATA  TTG  AAA  TGT  CTC  ATA  ACT  GGG 
kinase and [-r-32P] ATP (PLP-C: 5' CAGTTCCATCACTGGGGAGCC 3'; PLP-Cv: 5' CAGCTCCATCACTGAGGAGTT 3'). The labeled primer (final concentration 10 PM) was extracted with phenol/chloroform, precipitated with ethanol, and hybridized with 5 fig of total RNA from the junctional zone of the chorioallantoic placenta or from the spleen. RT was performed using Superscript preamplification system for first strand cDNA synthesis kit (Life Technologies). Reactions were terminated by the addition of sample running buffer (98% formamide, 2.5 rnr.4 EDTA, 0.1% bromophenol blue, 0.1% xylene cyanol) and then separated on a 6% polyacrylamide/7 M urea sequencing gel. A known DNA sequence was run on the same gel to indicate the size of the primer extended products.
PLP-Cv promoter analysis in trophoblast and nontrophoblast cell types 
a + and -= presence or absence of the rat gene, respectively. b + = rat chromosome present in more than 55% of the metaphases; (+) = rat chromosome present in 25-55% of the metaphases; (-) = rat chromosome present in less than 25% of the metaphases; -= rat chromosome absent.
' When a chromosome was present in less than 25% of the metaphases (-in parentheses), the hybrid in question was not taken in account to establish the number of discordancies for that particular chromosome.
sarcoma virus promoter-luciferase (RSV-Luc; positive control), or pGL-2 basic vector (negative control). An RSV promoter-P-GAL construct (RSV-P-GAL; 0.5 ~g) was cotransfected and used to evaluate transfection efficiency. Forty-eight hours following transfection, cells were collected, and lysates prepared via three cycles of freezing and thawing. Luciferase activity was measured with a luminometer according to the procedure of Brasier et al. (37) . P-GAL activities and total protein concentrations in the lysates were determined with a Galacto-Light kit (Tropix) and the protein-dye binding method (38) , respectively.
Results

Isolation and characterization of PLP-Cu genomic clones
Approximately 1 X lo6 pfu of phage were screened resulting in the identification of four positive phage clones: RGLC-31 (15.4 kb), RGLC-32 (16 kb), RGLC-43 (18.4 kb), and RGLC-44 (17 kb). Dot blot analysis with oligonucleotide probes corresponding to 5' and 3' regions of the PLP-C cDNA demonstrated that RGLC-31 and RGLC-32 clones contained the entire coding sequence, whereas RGLC-43 and RGLC-44 were incomplete lacking 5' and 3' regions, respectively. The restriction and Southern blot analyses of the RGLC-31 clone are summarized in Fig. 1 . Complete digestion with Not1 and Hind111 resulted in the generation of six fragments, two of which hybridized with the PLP-C probe in a Southern blot (2.8 and 3.6 kb), and were subsequently subcloned into pBluescript sk+ for sequencing. A third fragment (3.0 kb) generated from the Not I and Hind111 digestion and located immediately 5' to the hybridizing fragments was also subcloned into pBluescript sk+ for sequencing.
All exons and exon/intron boundaries were sequenced (Fig. 2) . Exonic regions showed extensive nucleotide homology to the PLP-C cDNA; however, significant differences were evident. The genomic clone was determined not to contain the PLP-C gene but instead a related gene that we termed PLP-C variant (PLP-Cv). Sequences from the three additional genomic clones (RGLC-32, RGLC-43, and RGLC-44) were analyzed. Each sequence was identical to RGLC31 corresponding to the PLP-Cv sequence. We initially hypothesized that PLP-Cv may represent an allele for PLP-C that was solely expressed in the Wistar Kyoto outbred rat (source of the genomic library). Placental RNA was analyzed from Wistar Kyoto outbred and Holtzman rats for PLP-C and PLP-Cv expression by RT-PCR. PLP-C and PLP-Cv were expressed in both strains (data not shown). The PLP-C gene has subsequently been isolated from the Wistar Kyoto outbred genomic library using a PCR-based strategy (data not shown). The organization of the PLP-Cv gene was determined by aligning the PLP-Cv cDNA (see below) with the corresponding regions of the RGLC-31 clone. The complete PLP-Cv cDNA sequence was identified in this clone, confirming that it contained the PLP-Cv gene. Consensus GT and AG splicing junctions were evident in each intron. The PLP-Cv gene was shown to exhibit a six exon and five intron arrangement, unique among members of the PRL family. The existence of the additional exonic and intronic sequences was further verified by PCR analysis using primers corresponding to exons 2, 3, and 4 of PLP-Cv. Comparison of the prototypical PRL family gene structure with the PLP-Cv gene indicated the existence of a unique exon 3 encoding for 13 amino acids in the PLP-Cv gene. Amino acids encoded by exon 3 of PLP-Cv are highly homologous to corresponding regions in the rat PLP-C, rat decidual/ trophoblast PRL-related protein (d / tPRP), and mouse proliferin related protein (PRP) sequences (15, 16, 39) . Genes encoding these proteins have not been cloned but may also possess the unique six exon and five intron structure exhibited by the PLP-Cv gene.
Chromosomal assignment
The PLP-Cv gene was localized using somatic cell hybrids that segregate rat chromosomes. PCR-based identification of (Figs. 2 and  3 ). An error was discovered in the published PLP-C sequence (15) between amino acids +131 to +136 (K. Shiverick, personal communication), which has been corrected (see Fig. 3 ). PLP-Cv showed 90 and 78% sequence identity with PLP-C at nucleotide and amino acid levels, respectively. The predicted PLP-Cv protein contains 238 amino acids and was calculated to possess a mol wt of 27,199 and a p1 of 5.9, virtually identical to PLP-C. Hydropathy plots for PLP-Cv and PLP-C were also very similar (Fig. 3) . PLP-Cv showed progressively less amino acid sequence identity with decidual / trophoblast PRL-related protein (d / tPRP, 58%), and proliferin related protein (PRP, 30%); however, the amino acid region associated with the unique exon 3 (Tyr4' to Leu53) is present in each of these PRL family members but not in other PRL family members (2, 16, 39) . Unlike PLP-C, which has two putative N-linked glycosylation sites at Asn3' and Asn18' (15), PLP-Cv possesses only a single site at Asn18' (see Fig. 2 ).
Tissue distribution of PLP-C and PLP-Cv
The sequence similarities between PLP-C and PLP-Cv dictated that we establish an assay that could distinquish between these two close relatives. A PCR-based strategy shown in Fig. 4 , used specific primers that resulted in the specific amplification of either PLP-C or PLP-Cv. The size of the amplified products was 780 bp. A survey of various tissues indicated that PLP-Cv and PLP-C were coordinately ex- Primer extension analysis was used to identify transcription start sites for PLP-C and PLP-Cv in junctional zone placenta. Several putative transcription start sites were identified for both PLP-C and PLP-Cv (Fig. 7) . These were located in two general regions relative to their respective translation start site (ATG), -43, and -60 nucleotides (Figs. 2 and 7 ). Sequence analysis of 5' flanking DNA corresponding to the PLP-Cv gene indicated the presence of consensus TATA boxes located -48 to -42 bp (ATATATA) and -234 to -229 (TATAAT) upstream of the most proximal transcription start site (see Fig. 2 ). Primer extended products were not generated from spleen RNA (Fig. 7) . tumor cells, or L929 fibroblasts (Fig. 8) . Similarly, the 2.1 kb PLP-Cv promoter-luciferase construct was active in the Rcho-1 trophoblast cells but not in the other cell lines (Fig. 8) .
The promoterless construct (pGL-2) showed minimal activity in each of the cell lines (Fig. 8 ). An RSV-Luc construct was maximally active in each of the cell lines, exhibiting luciferase activities greater than 1000 times activities noted for the promoterless construct (data not shown).
Discussion
In this report, we have identified and characterized a new member of the PRL gene family possessing considerable homology to PLP-C, a unique gene structure, and a trophoblast cell-specific pattern of transcriptional activation. This new member is referred to as PLP-C variant (PLP-Cv).
Members of the PRL family typically possess a five exon/ four intron gene organization that has been extremely well conserved across species (23-25, [40] [41] [42] . Partial 5' genomic clones for PLP-A and PLP-B are consistent with the five exon/four intron gene structure of PRL (13, (23) (24) (25) 43) . The PLP-Cv gene represents only the, second member of the rat PRL family to be completely characterized and the first shown to exhibit a six exon/ five intron arrangement (present study). Five of the exons are entirely homologous with exons from the PRL gene (Fig. 9) . The additional exon is situated between exons two and three of the prototypical PRL gene structure (Fig. 9) . Exon three of PLP-Cv is unique, relatively short, and encodes for a region rich in aromatic amino acids that also appears to be present in a subgroup of the PRL family, including PLP-C, d / tPRP, and mouse proliferin related protein (15, 16, 39) . Constituents of this subgroup do not appear to signal through the PRL receptor signaling pathway (22,44). Mouse proliferin related protein has been shown to antagonize blood vessel development (44) . It remains to be determined whether this subgroup shares similar biological actions and whether their actions are influenced by inclusion of an additional exon.
Each of the currently identified members of the rat PRL gene family (PRL, PL-I, PL-Iv, PL-II, PLP-A, PLP-8, PLP-C, PLP-Cv, and d/ tPRP) have been assigned to chromosome 17 of the rat genome (1,2,15,18,19); present study). The specific arrangement of these genes on chromosome 17 has not been reported. Members of the human and mouse PRL gene families have been assigned to human chromosome 6 and mouse chromosome 13, respectively (45, 46) . Only one member of the PRL gene family, PRL, has been identified in the human, whereas five members have been identified in the mouse. These include mouse homologs for PRL, PL-I, and PL-II plus two novel mouse genes, proliferin and proliferin related protein (45) . The arrangement of the mouse PRL family of genes on chromosome 13 has also not been reported. Physical relationships of the PRL family genes along their respective chromosomes may provide insights into the nature of the coordinated tissue-and cell-specific expression patterns for several of the PRL family genes.
Each of the members of the rat PRL family except PRL are expressed by trophoblast cells in a lineage-and temporalspecific pattern. The trophoblast ceil types involved are trophoblast giant cells and spongiotrophoblast cells. Tropho- (4, 5) and PL-II from midgestation until parturition (5, 9) . During the latter part of gestation, trophoblast giant cells are minor contributors to the production of PLP-A, PLP-C, and PL-Iv (5, 6, 9, 14, 15, 47). Spongiotrophoblast cells are the major sources of PLP-A, PLP-B, PLP-C, and PL-Iv, the exclusive trophoblast source of PLP-B, and are first expressed between between days 13 and 15 of gestation and continue until term (6, 7, 9, 14, 15, (47) (48) (49) . d / tPRP and PLP-B are also expressed during the first half of pregnancy in uterine decidual tissue (16, 50, 51). PLP-Cv exhibits a lineage-and temporal-specific expression pattern similar to PLP-C (present study), which also closely resembles the expression patterns for PLP-A and PL-Iv. Thus, cell-specific factors regulating trophoblast giant cells and spongiotrophoblast cells and temporal-specific factors active during the second half of gestation likely participate in the control of PLP-Cv gene activation. Some significant progress has been made in understanding the control of PRL family gene expression in trophoblast cells. Most of the data has been generated with either the Rcho-1 trophoblast cell line or through the use of transgenic approaches (43, 52) . Promoter constructs representing 5' flanking DNA associated with each of the PL-I, PLP-A, and PLP-Cv genes can direct reporter gene activities in Rcho-1 trophoblast cells (43, 52, 53) ; present study). More specifically, AP-1 and GATA elements and fos, jun, GATA-2, GATA3, and possibly the basic helix-loop-helix transcription factor, Hxt / Thing-l / eHAND, have been implicated in the control of PL-I promoter activity (43, (53) (54) (55) . GATA factors have also been implicated in the transcriptional control of the a-subunit gene of CG in human trophoblast cells (56) . A consensus GATA element is located within the first 300 bp upstream of the PLP-Cv gene proximal transcriptional start site; however, whether the element is functionally important remains to be determined. Rcho-1 trophoblast cells are restricted to the trophoblast giant cell lineage (27) and thus the above factors may contribute to the control of trophoblast giant cell PLP-Cv gene activation. As indicated above, PLP-Cv is also likely expressed in spongiotrophoblast cells. Research directed toward understanding regulatory factors governing spongiotrophoblast cell gene expression has been hindered by a paucity of in vitro models. Nonetheless, gene targeting strategies have implicated Mash-2, a basic helixloop-helix transcription factor (27, 57), and the epidermal growth factor receptor in the control of spongiotrophoblast POLY A SiTE (AATAAA) cell development (58, 59) . Consequently, Mash-2 and the epidermal growth factor receptor, either directly or indirectly, may also participate in the regulation of spongiotrophoblast cell PLP-Cv gene activation.
It is not yet entirely apparent why the rodent placenta expresses an array of genes related to PRL. Specificity concerning functions, expression patterns, and accessibility are certainly reasonable hypotheses. PLP-Cv is a newly identified member of the PRL family with structural features and expression patterns indicative of a role in the maintenance of pregnancy. The availability of the PLP-Cv cDNA and gene are necessary prerequisites for the implementation of additional molecular and transgenic strategies directed toward understanding the role of PLP-Cv in the physiology of pregnancy in the rat.
